These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1390277)
1. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. Klinge CM; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1992 Oct; 43(4):249-62. PubMed ID: 1390277 [TBL] [Abstract][Full Text] [Related]
2. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. Anolik JH; Klinge CM; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405 [TBL] [Abstract][Full Text] [Related]
3. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352 [TBL] [Abstract][Full Text] [Related]
4. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro. Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832 [TBL] [Abstract][Full Text] [Related]
5. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). Klinge CM J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353 [TBL] [Abstract][Full Text] [Related]
6. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Klinge CM; Peale FV; Hilf R; Bambara RA; Zain S Cancer Res; 1992 Mar; 52(5):1073-81. PubMed ID: 1737365 [TBL] [Abstract][Full Text] [Related]
7. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors. Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA. Klinge CM; Traish AM; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617 [TBL] [Abstract][Full Text] [Related]
9. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Anolik JH; Klinge CM; Hilf R; Bambara RA Biochemistry; 1995 Feb; 34(8):2511-20. PubMed ID: 7873531 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression. Klinge CM Mol Cell Endocrinol; 1999 Apr; 150(1-2):99-111. PubMed ID: 10411304 [TBL] [Abstract][Full Text] [Related]
12. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression. Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481 [TBL] [Abstract][Full Text] [Related]
13. hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro. Klinge CM; Brolly CL; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1997; 63(4-6):283-301. PubMed ID: 9459195 [TBL] [Abstract][Full Text] [Related]
14. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. Klinge CM; Bodenner DL; Desai D; Niles RM; Traish AM Nucleic Acids Res; 1997 May; 25(10):1903-12. PubMed ID: 9115356 [TBL] [Abstract][Full Text] [Related]
16. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632 [TBL] [Abstract][Full Text] [Related]
17. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965 [TBL] [Abstract][Full Text] [Related]
18. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Metzger D; Berry M; Ali S; Chambon P Mol Endocrinol; 1995 May; 9(5):579-91. PubMed ID: 7565805 [TBL] [Abstract][Full Text] [Related]
19. A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. Ludwig LB; Klinge CM; Peale FV; Bambara RA; Zain S; Hilf R Mol Endocrinol; 1990 Jul; 4(7):1027-33. PubMed ID: 2284005 [TBL] [Abstract][Full Text] [Related]
20. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Reese JC; Katzenellenbogen BS Nucleic Acids Res; 1991 Dec; 19(23):6595-602. PubMed ID: 1754396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]